Latigo priced its IPO at $18 a share for $345.6 million, one of the largest biotech raises of the year and…
As seen on the 24/7 Wall St. homepage on August 7, 2026.
Latigo Biotherapeutics, Inc.
LTGO · Nasdaq
$18 / share
$345.6M raise
19,200,000 shares
Latigo prices $345.6 million IPO at $18 a share
Latigo priced its IPO at $18 a share for $345.6 million, one of the largest biotech raises of the year and enough capital to push its non-opioid painkiller against Vertex's head start. Goldman Sachs, Jefferies, Leerink and Guggenheim ran the books.
Mentioned: LTGO